FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094164026> ?p ?o ?g. }

• W3094164026 endingPage "e628" @default.
• W3094164026 startingPage "e628" @default.
• W3094164026 abstract "Among patients with pancreatic cancer, radiotherapy has a role in offering patients local and overall control but data on patient reported outcomes remains scarce. We sought to quantify the patient reported outcomes (PROs) of pancreatic cancer patients receiving radiotherapy (RT) in order to improve patient-physician communication and shared decision making. As part of an IRB-approved study, we prospectively collected PRO data for 57 patients (28 male, 29 female, median age of 68 years [range, 41-83]) with non-metastatic pancreatic cancer who were treated with neoadjuvant chemotherapy (50% FOLFIRINOX, 42% gemcitabine and nab-paclitaxel, 8% other) and RT. Patients received stereotactic body radiation therapy (SBRT) (median dose: 36Gy, 5 fractions for all, n = 13), volumetric modulated arc therapy (VMAT) (median dose: 50.4Gy, 10-28 fractions, n = 20), intensity-modulated radiation therapy (IMRT) (median dose: 62Gy, 10-28 fractions, n = 13), or 3-dimensional conformal radiation treatment (3D-CRT) (median dose: 30Gy, 10-28 fractions, n = 13). All patients were seen by a multidisciplinary care team. PROs were collected using the validated MD Anderson Symptom Inventory for gastrointestinal cancer (MDASI-GI) questionnaire before the start of RT and after completion of RT. We used descriptive statistics to summarize the patients’ characteristics and MDASI-GI scores. We then performed subgroup analyses on the different radiation modalities and used the paired t-test to compare mean between pre-, and post-RT MDASI-GI scores. Median follow up time was 14.0 months and median overall survival was 24.4 months. No significant differences between pre-, and post-RT were found for the composite MDASI-GI score (mean difference: 0.04, 95% CI [-0.23 – 0.32], p = 0.76). Furthermore, there was no significant differences between pre-, and post- therapy for each radiation modality used. The 5 most-severe MDASI-GI items were fatigue, mouth dryness, numbness, taste disturbance, and decreased appetite. Compared to baseline, no increase in the proportion of patients reporting moderate to severe MDASI-GI items was noted in the IMRT group. In the 3D-CRT group, there was no increase in the proportion of patients reporting moderate to severe MDASI-GI items except for appetite (10% increase). Similarly, no change was noted in the SBRT and VMAT groups except for numbness (16% increase) and mouth dryness (8% increase) respectively. Different RT modalities do not seem to affect PROs in a clinically significant way for patients with pancreatic cancer. This may be related to modern medical management and newer radiation technologies. Future studies will investigate additional time points and correlate PRO data with outcomes." @default.
• W3094164026 created "2020-10-29" @default.
• W3094164026 creator A5002562403 @default.
• W3094164026 creator A5011254389 @default.
• W3094164026 creator A5011546832 @default.
• W3094164026 creator A5026500137 @default.
• W3094164026 creator A5026811385 @default.
• W3094164026 creator A5042435815 @default.
• W3094164026 creator A5042441942 @default.
• W3094164026 creator A5046059508 @default.
• W3094164026 creator A5059256779 @default.
• W3094164026 creator A5062204572 @default.
• W3094164026 creator A5066884681 @default.
• W3094164026 creator A5071185138 @default.
• W3094164026 creator A5079075847 @default.
• W3094164026 creator A5082668053 @default.
• W3094164026 creator A5083464790 @default.
• W3094164026 creator A5087201995 @default.
• W3094164026 creator A5089299130 @default.
• W3094164026 date "2020-11-01" @default.
• W3094164026 modified "2023-09-26" @default.
• W3094164026 title "Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing Radiotherapy" @default.
• W3094164026 doi "https://doi.org/10.1016/j.ijrobp.2020.07.1897" @default.
• W3094164026 hasPublicationYear "2020" @default.
• W3094164026 type Work @default.
• W3094164026 sameAs 3094164026 @default.
• W3094164026 citedByCount "0" @default.
• W3094164026 crossrefType "journal-article" @default.
• W3094164026 hasAuthorship W3094164026A5002562403 @default.
• W3094164026 hasAuthorship W3094164026A5011254389 @default.
• W3094164026 hasAuthorship W3094164026A5011546832 @default.
• W3094164026 hasAuthorship W3094164026A5026500137 @default.
• W3094164026 hasAuthorship W3094164026A5026811385 @default.
• W3094164026 hasAuthorship W3094164026A5042435815 @default.
• W3094164026 hasAuthorship W3094164026A5042441942 @default.
• W3094164026 hasAuthorship W3094164026A5046059508 @default.
• W3094164026 hasAuthorship W3094164026A5059256779 @default.
• W3094164026 hasAuthorship W3094164026A5062204572 @default.
• W3094164026 hasAuthorship W3094164026A5066884681 @default.
• W3094164026 hasAuthorship W3094164026A5071185138 @default.
• W3094164026 hasAuthorship W3094164026A5079075847 @default.
• W3094164026 hasAuthorship W3094164026A5082668053 @default.
• W3094164026 hasAuthorship W3094164026A5083464790 @default.
• W3094164026 hasAuthorship W3094164026A5087201995 @default.
• W3094164026 hasAuthorship W3094164026A5089299130 @default.
• W3094164026 hasBestOaLocation W30941640261 @default.
• W3094164026 hasConcept C121608353 @default.
• W3094164026 hasConcept C126322002 @default.
• W3094164026 hasConcept C143998085 @default.
• W3094164026 hasConcept C188816634 @default.
• W3094164026 hasConcept C2780210213 @default.
• W3094164026 hasConcept C2780258809 @default.
• W3094164026 hasConcept C509974204 @default.
• W3094164026 hasConcept C71924100 @default.
• W3094164026 hasConceptScore W3094164026C121608353 @default.
• W3094164026 hasConceptScore W3094164026C126322002 @default.
• W3094164026 hasConceptScore W3094164026C143998085 @default.
• W3094164026 hasConceptScore W3094164026C188816634 @default.
• W3094164026 hasConceptScore W3094164026C2780210213 @default.
• W3094164026 hasConceptScore W3094164026C2780258809 @default.
• W3094164026 hasConceptScore W3094164026C509974204 @default.
• W3094164026 hasConceptScore W3094164026C71924100 @default.
• W3094164026 hasIssue "3" @default.
• W3094164026 hasLocation W30941640261 @default.
• W3094164026 hasOpenAccess W3094164026 @default.
• W3094164026 hasPrimaryLocation W30941640261 @default.
• W3094164026 hasRelatedWork W1969578744 @default.
• W3094164026 hasRelatedWork W2005537476 @default.
• W3094164026 hasRelatedWork W2057062457 @default.
• W3094164026 hasRelatedWork W2059464886 @default.
• W3094164026 hasRelatedWork W2165480504 @default.
• W3094164026 hasRelatedWork W2171607164 @default.
• W3094164026 hasRelatedWork W2319496893 @default.
• W3094164026 hasRelatedWork W2361755712 @default.
• W3094164026 hasRelatedWork W2376347278 @default.
• W3094164026 hasRelatedWork W2752933315 @default.
• W3094164026 hasVolume "108" @default.
• W3094164026 isParatext "false" @default.
• W3094164026 isRetracted "false" @default.
• W3094164026 magId "3094164026" @default.
• W3094164026 workType "article" @default.